Membrane-bound pyrophosphatases are homodimeric integral membrane proteins that hydrolyze pyrophosphate into orthophosphates, coupled to the active transport of protons or sodium ions across membranes. They are important in the life cycle of bacteria, archaea, plants, and parasitic protists, but no homologous proteins exist in vertebrates, making them a promising drug target. Here, we report the first nonphosphorus allosteric inhibitor of the thermophilic bacterium Thermotoga maritima membrane-bound pyrophosphatase and its bound structure together with the substrate analog imidodiphosphate. The unit cell contains two protein homodimers, each binding a single inhibitor dimer near the exit channel, creating a hydrophobic clamp that inhibits the movement of β-strand 1–2 during pumping, and thus prevents the hydrophobic gate from opening. This asymmetry of inhibitor binding with respect to each homodimer provides the first clear structural demonstration of asymmetry in the catalytic cycle of membrane-bound pyrophosphatases.
Antibodies from individuals living in areas where malaria is endemic are known to react with parasitederived erythrocyte surface proteins. The major immunogenic and clonally variant surface antigen described to date is Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP-1), which is encoded by members of the multicopy var gene family. We report here that rifin proteins (RIF proteins), belonging to the largest known family of variable infected erythrocyte surface-expressed proteins, are also naturally immunogenic. Recombinant RIF proteins were used to analyze the antibody responses of individuals living in an area of intense malaria transmission. Elevated anti-rifin antibody levels were detected in the majority of the adult population tested, whereas the prevalence of such antibodies was much lower in malaria-exposed children. Despite the high degree of diversity between rif sequences and the high gene copy number, it appears that P. falciparum infections can induce antibodies that cross-react with several variant rifin molecules in many parasite isolates in a given community, and the immune response is most likely to be stable over time in a hyperendemic area. The protein was localized by fluorescence microscopy on the membrane of ring and young trophozoite-infected erythrocytes with antibodies from human immune sera with specificities for recombinant RIF protein.Malaria is a major public health problem in many parts of the world, especially in Africa. Each year 300 to 500 million people contract the disease, and between 1 and 2 million, mostly children under the age of 5 years, die (39). Immunity to Plasmodium falciparum malaria develops when an individual acquires a broad repertoire of specific protective antibodies to polymorphic antigens that are present on the surface of the infected erythrocyte (IE) and that undergo antigenic variation (4,5,12,14,22,27). Further studies show that antibodies to a number of other monomorphic epitopes may also contribute to protection against disease (1,2,8,15,25,28). Cell-mediated immune mechanisms are also known to play a role in the development of immunity to malaria (13).To date, P. falciparum erythrocyte membrane protein 1 (PfEMP-1), encoded by ca. 50 var genes, is the best-characterized surface antigen of IEs (3,31,33). The proteins expressed in knobs are highly divergent in their amino acid sequences and clonally variant. Antibodies to PfEMP-1 in sera of adults living in endemic areas recognize specific conserved, semivariable and hypervariable regions on the protein and associations between such antibodies and protection from severe disease have been shown (4,23,36).The recent analysis of the P. falciparum genome sequencing project has identified other multicopy gene families unique to Plasmodia, the largest of which belongs to the rif (repetitive interspersed family) gene family (7,11,37). This family of genes encoding 27-to 39-kDa membrane-associated proteins is estimated to be present in the order of ca. 200 copies. Rif genes have two exons, the first of wh...
SummaryIn malaria-endemic regions, pregnant women are more susceptible to malarial infections than nonpregnant women. The main objective of this study, which was conducted in the malaria hyperendemic town of Lambaréné (Gabon, Central Africa), was to characterize Plasmodium falciparum infections in peripheral, placental and cord blood from women of different gravidities with submicroscopic infections. Using the P. falciparum merozoite surface protein 2 (MSP 2)* gene as a polymorphic marker in polymerase chain reactions, we analysed genetic diversity and multiplicity of infection in isolates from all three kinds of samples of 184 pregnant women at delivery. We detected infection in 44% of the women who were originally negative by microscopy. Equally important was the finding that the placenta had the highest prevalence of infection (P < 0.001). There was no correlation with gravidity status or age of the patients. The multiplicities of infection in the peripheral and placental blood samples did not differ and single infection was observed in cord blood, independently of the gravidity. The FC27/MSP 2 was the predominant allelic family. The major FC27 alleles detected in the peripheral, placental and cord blood were sequenced and found to be closely related to the published K1 form sequence. Below microscopy level, the placenta remains the most infected organ and this submicroscopic carriage of parasites may contribute to the development and maintenance of immunity to malaria during pregnancy.keywords MSP 2 marker, polymerase chain reaction, submicroscopic infections, multiplicity of infections
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.